Opportunity Information: Apply for PAR 15 276
Apply for PAR 15 276
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Turkey US Collaborative Program for Affordable Medical Technologies (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.394 Cancer Detection and Diagnosis Research.
- This funding opportunity was created on Jun 11, 2015 and posted on Jun 11, 2015.
- Applicants must submit their applications by Jan 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Independent school districts Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education Public and State controlled institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Turkey-US Collaborative Program for Affordable Medical Technologies (R01) (Funding Opportunity Number PAR-15-276) is a National Institutes of Health (NIH) grant opportunity designed to support joint research partnerships between scientists based in the United States and scientists in Turkey. The core purpose is to speed up the development of diagnostic and therapeutic medical technologies that are genuinely affordable and practical for low- and middle-resource settings. In this program, "appropriate" technologies are framed very specifically: they should be usable in real-world settings with constrained infrastructure, cost-effective relative to local resources, sustainable over time (including maintenance, supply chains, training, and operating requirements), and effective at addressing a meaningful clinical need in populations where standard high-cost approaches may not be feasible. The intent is not just innovation for innovation's sake, but development that matches the realities of healthcare delivery in resource-limited environments across different world regions.
This opportunity uses the NIH R01 grant mechanism, which typically supports discrete, investigator-driven research projects with a defined scientific scope and set of aims. The funded work is expected to move technology development forward in a way that accelerates readiness for use, whether that involves prototyping, validation, optimization for field conditions, or other applied research steps necessary to translate an idea into something that can be deployed where it is needed. The program is aligned with NIH activity areas that include technological innovation to improve human health (CFDA 93.286) and cancer detection and diagnosis research (CFDA 93.394), signaling that relevant applications may span broad health technology development while also including disease areas such as oncology diagnostics.
From an administrative standpoint, this FOA falls under a discretionary grant category, with no cost sharing or matching requirement. The listed award ceiling is $100,000, indicating a funding cap associated with awards under this announcement as presented in the provided source data. Key timeline information in the source indicates the FOA was posted on June 11, 2015, with an original and current closing date of January 7, 2018, and an archive date of February 7, 2018, meaning the opportunity is no longer open for new applications under that specific announcement as of the archive date.
Eligibility is broad across many common U.S.-based applicant types, including public and private institutions of higher education, nonprofits (both 501(c)(3) and certain non-501(c)(3) entities), for-profit organizations (other than small businesses are explicitly listed, and small businesses are also listed), and a wide range of government entities (state, county, city/township, special district), as well as public housing authorities and independent school districts. Additional eligible categories called out include minority-serving institutions and other designated organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. A major constraint is that non-U.S. entities (foreign institutions) are not eligible to apply directly, and non-U.S. components of U.S. organizations are also not eligible to apply; however, foreign components are allowed as defined by the NIH Grants Policy Statement. In practical terms, that structure supports U.S.-led applications that formally integrate a Turkish collaboration through allowable partnership arrangements rather than having a Turkish institution submit as the primary applicant.
Overall, PAR-15-276 is aimed at building structured, binational research teams that can combine U.S. and Turkish scientific strengths to deliver medical technologies that fit the constraints of lower-resource clinical environments. The emphasis on affordability, usability, sustainability, and demonstrated clinical relevance is central, with the expectation that proposals will be grounded in real implementation conditions rather than assuming high-cost infrastructure, extensive specialized staffing, or fragile supply chains. For full details, NIH provided an announcement link (http://grants.nih.gov/grants/guide/pa-files/PAR-15-276.html) and directed technical access questions to the NIH Office of Extramural Research webmaster (FBOWebmaster@OD.NIH.GOV).
FAQs: Turkey-US Collaborative Program for Affordable Medical Technologies (R01) (PAR-15-276)
What is PAR-15-276?
PAR-15-276 is an NIH (National Institutes of Health) funding opportunity titled "The Turkey-US Collaborative Program for Affordable Medical Technologies (R01)." It supports collaborative research partnerships between scientists in the United States and scientists in Turkey to develop diagnostic and therapeutic medical technologies that are affordable and practical in low- and middle-resource settings.
What is the main goal of this program?
The program aims to speed up the development of medical technologies that are not only innovative, but also realistically deployable in real-world healthcare environments with constrained infrastructure and resources. The focus is on affordability, practicality, sustainability, and meaningful clinical impact.
What does the program mean by "appropriate" medical technologies?
In this program, "appropriate" technologies are defined as technologies that can be used in real-world settings with limited infrastructure, are cost-effective relative to local resources, are sustainable over time (including maintenance, supply chains, training, and operational requirements), and effectively address a meaningful clinical need where high-cost approaches may not be feasible.
What kinds of technologies are in scope?
The opportunity targets diagnostic and therapeutic medical technologies. The description emphasizes applied development steps such as prototyping, validation, and optimization for field conditions to move a technology toward readiness for use in low- and middle-resource environments.
Does this opportunity focus on any particular health areas?
The program is aligned with NIH activity areas that include technological innovation to improve human health (CFDA 93.286) and cancer detection and diagnosis research (CFDA 93.394). This suggests applications may be broad across health technology development and can include areas such as oncology diagnostics.
What grant mechanism does PAR-15-276 use?
This opportunity uses the NIH R01 grant mechanism, which typically supports discrete, investigator-driven research projects with a defined scope and set of scientific aims.
What kinds of project activities are expected under an R01 for this program?
Funded work is expected to advance technology development toward readiness for real use. Examples noted include prototyping, validation, and optimization for field conditions, as well as other applied research steps needed to translate an idea into a deployable technology.
Who is eligible to apply?
Eligibility is broad for U.S.-based applicant types. Listed eligible applicants include public and private institutions of higher education; nonprofits (501(c)(3) and certain non-501(c)(3) entities); for-profit organizations; small businesses; and many government entities (state, county, city/township, special district). Additional eligible categories include public housing authorities, independent school districts, minority-serving institutions, and other designated organizations (including HBCUs, Hispanic-serving Institutions, TCCUs, Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs), as well as faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
Can a Turkish institution apply as the primary applicant?
No. Non-U.S. entities (foreign institutions) are not eligible to apply directly as the primary applicant under this announcement, and non-U.S. components of U.S. organizations are also not eligible to apply.
Are any foreign components allowed at all?
Yes. Foreign components are allowed as defined by the NIH Grants Policy Statement. Practically, this supports U.S.-led applications that formally integrate a Turkish collaboration through allowable partnership arrangements, rather than having a Turkish institution submit as the primary applicant.
Is cost sharing or matching required?
No. The announcement is described as a discretionary grant with no cost sharing or matching requirement.
What is the funding cap (award ceiling) listed for this opportunity?
The provided source data lists an award ceiling of $100,000, indicating a funding cap associated with awards under this announcement as presented in the source information.
Is this funding opportunity still open?
No. The source information indicates the FOA was posted on June 11, 2015; the closing date (original and current) was January 7, 2018; and the archive date was February 7, 2018. Based on that archive date, the opportunity is no longer open for new applications under PAR-15-276.
What are the key dates listed for this FOA?
Posted date: June 11, 2015. Closing date: January 7, 2018 (original and current). Archive date: February 7, 2018.
What is the program trying to avoid in proposed technology development?
The emphasis is on technologies that fit the realities of resource-limited healthcare delivery. Proposals should not assume high-cost infrastructure, extensive specialized staffing, or fragile supply chains. Sustainability and practical usability are central expectations.
What is the collaboration model this program is trying to build?
The program is aimed at building structured, binational research teams that combine U.S. and Turkish scientific strengths to deliver affordable medical technologies that can work in low- and middle-resource clinical environments across different world regions.
Where can applicants find the original NIH announcement?
NIH provided the announcement link as: http://grants.nih.gov/grants/guide/pa-files/PAR-15-276.html
Who should be contacted for technical access questions about the NIH site or announcement?
The provided contact for technical access questions is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: NIDDK Centers for Diabetes Translation Research (P30)
Previous opportunity: BLM OR/WA Prineville Youth Partnership, Prineville District, Oregon
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 276
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 276) also looked into and applied for these:
| Funding Opportunity |
|---|
| Multidisciplinary Studies of HIV/AIDS and Aging (R01) Apply for PAR 15 280 Funding Number: PAR 15 280 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R03) Apply for PAR 15 281 Funding Number: PAR 15 281 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21) Apply for PAR 15 282 Funding Number: PAR 15 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R21) Apply for PAR 15 284 Funding Number: PAR 15 284 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R01) Apply for PAR 15 283 Funding Number: PAR 15 283 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| The Pancreatic Cancer Detection Consortium (U01) Apply for PAR 15 289 Funding Number: PAR 15 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Apply for PAR 15 297 Funding Number: PAR 15 297 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44) Apply for RFA DA 16 005 Funding Number: RFA DA 16 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42) Apply for RFA DA 16 006 Funding Number: RFA DA 16 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Supplements to Support Evaluation of the NCI Cancer Genomics Cloud Pilots (Admin Supp) Apply for PA 15 305 Funding Number: PA 15 305 Agency: National Institutes of Health Category: Education Health Funding Amount: $40,000 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R01) Apply for PA 15 311 Funding Number: PA 15 311 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R21) Apply for PA 15 310 Funding Number: PA 15 310 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Imaging Science Track Award for Research Transition (I/START) (R03) Apply for PAR 15 326 Funding Number: PAR 15 326 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP1) Apply for RFA DA 16 007 Funding Number: RFA DA 16 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Early Stage Development of Informatics Technologies for Cancer Research and Management (U01) Apply for PAR 15 332 Funding Number: PAR 15 332 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24) Apply for PAR 15 331 Funding Number: PAR 15 331 Agency: National Institutes of Health Category: Education Health Funding Amount: $600,000 |
| Sustained Support for Informatics Resources for Cancer Research and Management (U24) Apply for PAR 15 333 Funding Number: PAR 15 333 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) Apply for PAR 15 334 Funding Number: PAR 15 334 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Exploratory Multi site Palliative Care Research in Diverse Populations Utilizing the Palliative Care Research Cooperative (PCRC) Group (R21) Apply for PAR 15 337 Funding Number: PAR 15 337 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NIDA Translational Avant Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) Apply for RFA DA 16 008 Funding Number: RFA DA 16 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 276", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.